Nalaganje...
Adoptive immunotherapy against ovarian cancer
The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find new therapeutic options, cancer cells invariably develop d...
Shranjeno v:
| izdano v: | J Ovarian Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869278/ https://ncbi.nlm.nih.gov/pubmed/27188274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0236-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|